216 related articles for article (PubMed ID: 34912331)
1. MIR337-3p Enhances Mycobacterial Pathogenicity Involving TLR4/MYD88 and STAT3 Signals, Impairing VDR Antimicrobial Response and Fast-Acting Immunity.
Liang S; Huang G; Wu T; Peng Y; Liu X; Ji X; Sha W; Wang F; Shen L; Shen H
Front Immunol; 2021; 12():739219. PubMed ID: 34912331
[TBL] [Abstract][Full Text] [Related]
2. Containment of aerogenic Mycobacterium tuberculosis infection in mice does not require MyD88 adaptor function for TLR2, -4 and -9.
Hölscher C; Reiling N; Schaible UE; Hölscher A; Bathmann C; Korbel D; Lenz I; Sonntag T; Kröger S; Akira S; Mossmann H; Kirschning CJ; Wagner H; Freudenberg M; Ehlers S
Eur J Immunol; 2008 Mar; 38(3):680-94. PubMed ID: 18266299
[TBL] [Abstract][Full Text] [Related]
3. [Frontier of mycobacterium research--host vs. mycobacterium].
Okada M; Shirakawa T
Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
[TBL] [Abstract][Full Text] [Related]
4. Induction of autophagy through CLEC4E in combination with TLR4: an innovative strategy to restrict the survival of
Pahari S; Negi S; Aqdas M; Arnett E; Schlesinger LS; Agrewala JN
Autophagy; 2020 Jun; 16(6):1021-1043. PubMed ID: 31462144
[TBL] [Abstract][Full Text] [Related]
5. A CD4+CD161+ T-Cell Subset Present in Unexposed Humans, Not Tb Patients, Are Fast Acting Cells That Inhibit the Growth of Intracellular Mycobacteria Involving CD161 Pathway, Perforin, and IFN-γ/Autophagy.
Yang R; Peng Y; Pi J; Liu Y; Yang E; Shen X; Yao L; Shen L; Modlin RL; Shen H; Sha W; Chen ZW
Front Immunol; 2021; 12():599641. PubMed ID: 33732233
[TBL] [Abstract][Full Text] [Related]
6. Toll-like receptor 4 expression is required to control chronic Mycobacterium tuberculosis infection in mice.
Abel B; Thieblemont N; Quesniaux VJ; Brown N; Mpagi J; Miyake K; Bihl F; Ryffel B
J Immunol; 2002 Sep; 169(6):3155-62. PubMed ID: 12218133
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-708-5p regulates mycobacterial vitality and the secretion of inflammatory factors in Mycobacterium tuberculosis-infected macrophages by targeting TLR4.
Li WT; Zhang Q
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):8028-8038. PubMed ID: 31599428
[TBL] [Abstract][Full Text] [Related]
8. IL-1 receptor-mediated signal is an essential component of MyD88-dependent innate response to Mycobacterium tuberculosis infection.
Fremond CM; Togbe D; Doz E; Rose S; Vasseur V; Maillet I; Jacobs M; Ryffel B; Quesniaux VF
J Immunol; 2007 Jul; 179(2):1178-89. PubMed ID: 17617611
[TBL] [Abstract][Full Text] [Related]
9. Natural and trained innate immunity against Mycobacterium tuberculosis.
Ferluga J; Yasmin H; Al-Ahdal MN; Bhakta S; Kishore U
Immunobiology; 2020 May; 225(3):151951. PubMed ID: 32423788
[TBL] [Abstract][Full Text] [Related]
10. Genetics and Functional Mechanisms of STAT3 Polymorphisms in Human Tuberculosis.
Wang F; Huang G; Shen L; Peng Y; Sha W; Chen ZW; Shen H
Front Cell Infect Microbiol; 2021; 11():669394. PubMed ID: 34307193
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-325-3p Facilitates Immune Escape of Mycobacterium tuberculosis through Targeting LNX1 via NEK6 Accumulation to Promote Anti-Apoptotic STAT3 Signaling.
Fu B; Xue W; Zhang H; Zhang R; Feldman K; Zhao Q; Zhang S; Shi L; Pavani KC; Nian W; Lin X; Wu H
mBio; 2020 Jun; 11(3):. PubMed ID: 32487755
[TBL] [Abstract][Full Text] [Related]
12. Mice lacking myeloid differentiation factor 88 display profound defects in host resistance and immune responses to Mycobacterium avium infection not exhibited by Toll-like receptor 2 (TLR2)- and TLR4-deficient animals.
Feng CG; Scanga CA; Collazo-Custodio CM; Cheever AW; Hieny S; Caspar P; Sher A
J Immunol; 2003 Nov; 171(9):4758-64. PubMed ID: 14568952
[TBL] [Abstract][Full Text] [Related]
13. Impaired innate immunity in Tlr4(-/-) mice but preserved CD8+ T cell responses against Trypanosoma cruzi in Tlr4-, Tlr2-, Tlr9- or Myd88-deficient mice.
Oliveira AC; de Alencar BC; Tzelepis F; Klezewsky W; da Silva RN; Neves FS; Cavalcanti GS; Boscardin S; Nunes MP; Santiago MF; Nóbrega A; Rodrigues MM; Bellio M
PLoS Pathog; 2010 Apr; 6(4):e1000870. PubMed ID: 20442858
[TBL] [Abstract][Full Text] [Related]
14. MiR-23a-5p modulates mycobacterial survival and autophagy during mycobacterium tuberculosis infection through TLR2/MyD88/NF-κB pathway by targeting TLR2.
Gu X; Gao Y; Mu DG; Fu EQ
Exp Cell Res; 2017 May; 354(2):71-77. PubMed ID: 28327409
[TBL] [Abstract][Full Text] [Related]
15. Mycobacterium tuberculosis ESAT6 modulates host innate immunity by downregulating miR-222-3p target PTEN.
Zonghai C; Tao L; Pengjiao M; Liang G; Rongchuan Z; Xinyan W; Wenyi N; Wei L; Yi W; Lang B
Biochim Biophys Acta Mol Basis Dis; 2022 Jan; 1868(1):166292. PubMed ID: 34710568
[TBL] [Abstract][Full Text] [Related]
16. IL-12+IL-18 Cosignaling in Human Macrophages and Lung Epithelial Cells Activates Cathelicidin and Autophagy, Inhibiting Intracellular Mycobacterial Growth.
Yang R; Yang E; Shen L; Modlin RL; Shen H; Chen ZW
J Immunol; 2018 Apr; 200(7):2405-2417. PubMed ID: 29453279
[TBL] [Abstract][Full Text] [Related]
17. Toll-like receptor 4 signaling-mediated responses are critically engaged in optimal host protection against highly virulent
Park J; Kim H; Kwon KW; Choi HH; Kang SM; Hong JJ; Shin SJ
Virulence; 2020 Dec; 11(1):430-445. PubMed ID: 32403973
[TBL] [Abstract][Full Text] [Related]
18. Monocytic-Myeloid Derived Suppressor Cells of HIV-Infected Individuals With Viral Suppression Exhibit Suppressed Innate Immunity to
Namdev P; Patel S; Sparling B; Garg A
Front Immunol; 2021; 12():647019. PubMed ID: 33995365
[TBL] [Abstract][Full Text] [Related]
19. CD40 ligand and interferon-γ induce an antimicrobial response against Mycobacterium tuberculosis in human monocytes.
Klug-Micu GM; Stenger S; Sommer A; Liu PT; Krutzik SR; Modlin RL; Fabri M
Immunology; 2013 May; 139(1):121-8. PubMed ID: 23289765
[TBL] [Abstract][Full Text] [Related]
20. Cutting edge: Toll-like receptor (TLR)2- and TLR4-mediated pathogen recognition in resistance to airborne infection with Mycobacterium tuberculosis.
Reiling N; Hölscher C; Fehrenbach A; Kröger S; Kirschning CJ; Goyert S; Ehlers S
J Immunol; 2002 Oct; 169(7):3480-4. PubMed ID: 12244136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
